|
Diabetes Technology & Therapeutics
The Intelligent Dosing System: Application for Insulin Therapy and Diabetes Management
To cite this article:
Curtiss B. Cook, John P. McMichael, Ron Lieberman, Linda J. Mann, Esther C. King, Katina M. New, Pamela S. Vaughn, Virginia G. Dunbar, Jane M. Caudle.
Diabetes Technology & Therapeutics.
February 2005,
7(1): 58-71.
doi:10.1089/dia.2005.7.58.
Curtiss B. Cook, M.D.Division of Endocrinology, Mayo Clinic, Scottsdale, Arizona. John P. McMichael, B.S.Dimensional Dosing Systems, Wexford, Pennsylvania. Ron Lieberman, M.D.Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland. Linda J. Mann, B.S.N.Grady Health System, Atlanta, Georgia. Esther C. King, B.S.N.Grady Health System, Atlanta, Georgia. Katina M. New, M.S.Grady Health System, Atlanta, Georgia. Pamela S. Vaughn, B.S.N.Grady Health System, Atlanta, Georgia. Virginia G. Dunbar, B.S.Grady Health System, Atlanta, Georgia. Jane M. Caudle, M.Ln.Grady Health System, Atlanta, Georgia. Diabetes mellitus is an increasing public health problem. Insulin is an essential tool in the management of hyperglycemia, but methods of dose adjustment are purely empirical. The Intelligent Dosing System (IDS®, Dimensional Dosing Systems, Inc., Wexford, PA) is a software suite that incorporates patient-specific, dose–response data in a mathematical model and then calculates the new dose of the medication needed to achieve the next desired therapeutic goal. We discuss the application of the IDS in insulin management. The IDS concept and the initial modeling used to construct an insulin doser are reviewed first. Additional data are then provided on the use of the IDS for titrating insulin therapy in a clinical setting. Finally, recent modifications in the IDS software and future applications of this technology for insulin dosing and diabetes management are discussed.  This paper was cited by:Description and Preliminary Evaluation of a Multiagent Intelligent Dosing System (MAIDS™) to Manage Combination Insulin–Oral Agent Therapy in Type 2 Diabetes Curtiss B. Cook, John P. Mcmichael, Virginia G. Dunbar, Ron Lieberman Diabetes Technology & Therapeutics. Dec 2005, Vol. 7, No. 6: 937-947 Abstract | Full Text PDF | Reprints & PermissionsResponse to Bequette and Desemone Regarding the Intelligent Dosing System Curtiss B. Cook, John P. McMichael Diabetes Technology & Therapeutics. Aug 2005, Vol. 7, No. 4: 658-661 First Page | Full Text PDF | Reprints & PermissionsEditorial: Symposium on Algorithms for Continuous Glucose Monitoring and Control B. Wayne Bequette Diabetes Technology & Therapeutics. Feb 2005, Vol. 7, No. 1: 1-2 First Page | Full Text PDF | Reprints & Permissions
|
|